Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added navigation/help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and updated the 'Intervention/Treatment' heading (replacing the older 'Intervention / Treatment'). The changes also include the addition 'No longer looking for participants' and revision tag updated to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-13T01:32:22.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, signaling a small system or content update. This change does not modify study details or other user-visible content.
    Difference
    0.0%
    Check dated 2026-06-05T22:44:04.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous v3.5.3.
    Difference
    0.0%
    Check dated 2026-05-22T16:13:41.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page footer now shows an updated site revision number (from v3.5.2 to v3.5.3), indicating a new release of the ClinicalTrials.gov interface without altering the study information presented.
    Difference
    0.0%
    Check dated 2026-04-24T06:39:15.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:48:28.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The Publications section was updated to include the 2024 Blood article by Friedberg et al. on frontline brentuximab vedotin therapy for older HL patients ineligible for chemotherapy, and the Erratum for that Blood article was removed.
    Difference
    0.0%
    Check dated 2026-04-02T15:35:03.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.